X

Blog

QualityStocksNewsBreaks – Moleculin Biotech Inc. (NASDAQ: MBRX) Secures $78M in Underwritten Public Offering

Moleculin Biotech (NASDAQ: MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors…

QualityStocks

QualityStocksNewsBreaks – Gage Growth Corp. Announces Expansion of COOKIES Retail Footprint in Michigan

Gage Growth Corp. (d.b.a. Gage Cannabis), a leading high-quality cannabis brand and operator in Michigan, has announced that it will…

QualityStocks

Brain Scientific Inc. (BRSF) Making EEGs Accessible in Emergency Departments

Head CTs, MRIs are most-used but not most-effective tool for head trauma or neurological issues in triage EEG changed clinical…

QualityStocks

Predictive Oncology Inc. (NASDAQ: POAI) Announces Fundraising Agreements to Raise Estimated $25M

POAI completes two separate fundraising initiatives: private placement, direct offering. Two fundraising campaigns expected to result in $17.6 million, $7.4…

QualityStocks

Uranium Energy Corp. (NYSE American: UEC) Positioned Favorably to Capitalize on Rising Uranium Demand

Increased nuclear power projects fueling rising demand for uranium UEC controls one of the largest historical uranium exploration and development…

QualityStocks

QualityStocksNewsBreaks – Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Shifts into Growth Mode with Recent Fundraising, Acquisition Announcements

Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF), a Portland-based cannabis company widely recognized for its Chalice Farms stores and…

QualityStocks

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) and WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) Get the Green Light for Clinical Trials’ Protocols from Ethics Panels

CNS Pharmaceuticals holds the exclusive worldwide license to the Berubicin chemical compound Berubicin is CNSP’s lead, novel anthracycline candidate for…

QualityStocks

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Establishes Clinical Advisory Board to Help Drive Growth

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered…

QualityStocks

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Reaches Milestone: Ladenburg Thalmann & Co. Inc. Signs Market Maker Intention Letter

Kaival Brands Innovations Group (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant…

QualityStocks

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Participate in Upcoming Stephens Best Ideas Conference

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics (“DTx”) market, has been selected to participate in the virtual…

QualityStocks